Endocrine Abstracts

Primary hyperparathyroidism (PHPT) is rare in pregnancy, with an incidence of 1%. It is associated with maternal, fetal, and neonatal complications. Treatment options include both medical and surgical approaches. Parathyroidectomy is the definitive and preferred treatment, especially when serum calcium level is higher than 10.8 mg/dl and with a prior history of pregnancy loss. Herein, we present two cases of gestational primary hyperparathyroidism with different treatments.</p...

Pembrolizumab is a monoclonal antibody (ab) that exerts antineoplastic effects by inhibiting the immunoevasive effects PD-1 grants cancer cells. It’s used to treat several forms of cancer, including melanoma and non-small cell lung cancer. Despite the promise pembrolizumab has demonstrated, it has been associated with immune-related adverse events. In this report, we describe the first case of both thyroiditis and hypophysitis occurring during active pembrolizumab t...